...
首页> 外文期刊>Biotechnology Progress >LPS Removal from an E. Coli Fermentation Broth Using Aqueous Two-Phase Micellar System
【24h】

LPS Removal from an E. Coli Fermentation Broth Using Aqueous Two-Phase Micellar System

机译:使用水相两相胶束系统去除大肠杆菌发酵液中的LPS

获取原文
获取原文并翻译 | 示例

摘要

In biotechnology, endotoxin (LPS) removal from recombinant proteins is a critical and challenging step in the preparation of injectable therapeutics, as endotoxin is a natural component of bacterial expression systems widely used to manufacture therapeutic proteins. The viability of large-scale industrial production of recombinant biomolecules of pharmaceutical interest significantly depends on the separation and purification techniques used. The aim of this work was to evaluate the use of aqueous two-phase micellar system (ATPMS) for endotoxin removal from preparations containing recombinant proteins of pharmaceutical interest, such as green fluorescent protein (GFPuv). Partition assays were carried out initially using pure LPS, and afterwards in the presence of E. coli cell lysate. The ATPMS technology proved to be effective in GFPuv recovery, preferentially into the micelle-poor phase (K_(GFPuv) < 1.00), and LPS removal into the micelle-rich phase (%REM_(LPS) >98.00%), Therefore, this system can be exploited as the first step for purification in biotechnology processes for removal of higher LPS concentrations.
机译:在生物技术中,从重组蛋白中去除内毒素(LPS)是制备可注射治疗剂的关键和挑战性步骤,因为内毒素是被广泛用于生产治疗性蛋白的细菌表达系统的天然成分。大规模工业化生产具有药用价值的重组生物分子的可行性在很大程度上取决于所使用的分离和纯化技术。这项工作的目的是评估使用含水两相胶束系统(ATPMS)从含有药物感兴趣的重组蛋白(例如绿色荧光蛋白(GFPuv))的制剂中去除内毒素的用途。最初使用纯LPS进行分区测定,然后在大肠杆菌细胞裂解液存在下进行分配测定。事实证明,ATPMS技术可有效回收GFPuv,优先进入贫胶团阶段(K_(GFPuv)<1.00),并去除LPS进入富胶团阶段(%REM_(LPS)> 98.00%),因此,该系统可以用作生物技术流程中纯化的第一步,以去除较高的LPS浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号